Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 31084
Evènement :Gene Therapy for Blood Disorders

Dates :Mardi 03 Mars 2020 - Jeudi 05 Mars 2020

Lieu :Courtyard by Marriott Boston Downtown
275 Tremont Street
02116 Boston, Massachusetts, États-Unis

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

Revolutionary gene therapies are redefining the treatment of blood diseases.
 
With an approved gene therapy treatment for β-thalassemia in the EU, and hemophilia candidates seeking 2020 approval in the USA and beyond, pioneers in the space must overcome hurdles they have never previously encountered to transform their clinical candidates into a commercial reality. Gene Therapy for Blood Disorders will unite industry leaders across the blood disease space to delve into the specific clinical and commercial challenges faced by companies developing gene therapies for hemophilia, sickle cell disease and β-thalassemia.
 
Evaluate the best strategies for a commercial launch in blood disease, optimize your trial design, gain insights on revolutionary novel technologies, and ultimately enhance your current hematology gene therapy program to bring transformative treatments to patients more quickly and efficiently.
 
URLs:
 
Prices:
Conference Only Industry - Early Rate: USD 2299.00
Conference Only Industry - Standard Rate: USD 2899.00
Conference Only Academic - Early Rate: USD 1899.00
Conference Only Academic - Standard Rate: USD 2499.00
 
Speakers: Grant Blouse Catalyst Biosciences, Julianne Bruno CRISPR Therapeutics, John Chapin CRISPR Therapeutics, Colleen Dansereau Boston Children’s Hospital, Mrudula Donepudi Editas Medicine, Catalina Driscoll Sanofi Genzyme, Dean Falb LogicBio, Meghan Gallagher bluebird bio, Nicolas Garnier Pfizer Rare Disease, Angela Johnson Sigilon Therapeutics, Paul Monahan Spark Therapeutics, Dawn Rotellini National Hemophilia Foundation, Eileen Sawyer uniQure, Julian Down Poseida Therapeutics, Matt Trudeau bluebird bio, Sander van Deventer uniQure, John Woolley University of Liverpool
 
Time: 9:00 am to 5:00 pm

Lieu

Plan et itinéraire
Adresse de la conférence :
Courtyard by Marriott Boston Downtown
275 Tremont Street
02116 Boston
Massachusetts, États-Unis
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

Gene Therapy for Blood Disorders Pharmacie
--
Tout public
-- -- --
English

Divers

Pour plus d'informations sur Gene Therapy for Blood Disorders, veuillez contacter Hanson Wade

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement